ArticleTheranostics2026

A tumor-targeted heptamethine cyanine dye induces suppression of progesterone receptor activity to treat hormone receptor-positive breast cancer.

Yoonbin Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.